{
    "clinical_study": {
        "@rank": "106077", 
        "arm_group": {
            "arm_group_label": "follow up", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "It is generally estimated that 5 % of patients with thyroid cancer will develop distant\n      metastases, and most of them had an advanced stage of the disease at presentation. Thirty\n      per cent of them are resistant to radio iodine therapy and are called \"refractory\". Their\n      long term survival is estimated to be less than 10 %.\n\n      The objective of this study is to identify the factors associated with poor outcome in a\n      cohort of patients with advanced thyroid cancer followed during 5 years. Anaplastic and\n      medullary thyroid carcinomas were excluded."
        }, 
        "brief_title": "Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)", 
        "completion_date": {
            "#text": "May 2022", 
            "@type": "Anticipated"
        }, 
        "condition": "Thyroid Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Thyroid Neoplasms", 
                "Thyroid Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Man or woman \u2265 18 years.\n\n          -  Thyroid cancer differentiated from follicular origins (papillary, vesicular or poorly\n             differentiated carcinoma).\n\n          -  TNM classification: stage pT3 (\u22652 cm), or pT4 or M1 at diagnosis.\n\n          -  Patient after post operative radioiodine therapy.\n\n        Exclusion Criteria:\n\n          -  Patient who can not be followed during the protocol.\n\n          -  Patient who does not consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02156362", 
            "org_study_id": "2011.665"
        }, 
        "intervention": {
            "arm_group_label": "follow up", 
            "description": "At least 1 follow up visit per year will be done and an additional visit if needed.", 
            "intervention_name": "follow up visit", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Thyroid carcinoma", 
            "predictive factors", 
            "refractory", 
            "Differentiated", 
            "follicular origin"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "location": {
            "contact": {
                "email": "claire.bournaud-salinas@chu-lyon.fr", 
                "last_name": "Claire BOURNAUD, MD", 
                "phone": "+33472356999"
            }, 
            "contact_backup": {
                "email": "francoise.borson-chazot@chu-lyon.fr", 
                "last_name": "Fran\u00e7oise BORSON-CHAZOT, PHD,MD", 
                "phone": "+33472119319"
            }, 
            "facility": {
                "address": {
                    "city": "Bron cedex", 
                    "country": "France", 
                    "zip": "69677"
                }, 
                "name": "Hospices Civils de Lyon-Centre de M\u00e9decine Nucl\u00e9aire Groupement Hospitalier Est 59 boulevard Pinel"
            }, 
            "investigator": {
                "last_name": "Claire BOURNAUD, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)", 
        "overall_contact": {
            "email": "claire.bournaud-salinas@chu-lyon.fr", 
            "last_name": "Claire BOURNAUD, MD", 
            "phone": "+33472356999"
        }, 
        "overall_contact_backup": {
            "email": "francoise.borson-chazot@chu-lyon.fr", 
            "last_name": "Fran\u00e7oise BORSON-CHAZOT, PHD,MD", 
            "phone": "+33472119319"
        }, 
        "overall_official": {
            "affiliation": "Hospices Civils de Lyon- Centre de M\u00e9decine Nucl\u00e9aire Groupement hospitalier est, 59 boulevard Pinel, 69677 Bron cedex", 
            "last_name": "Claire BOURNAUD, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of Thyroid cancer evolving to refractory stage", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02156362"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hospices Civils de Lyon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospices Civils de Lyon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}